JP Morgan Upgrades RXO to Neutral, Raises Price Target to $30

Benzinga · 2d ago
JP Morgan analyst Brian Ossenbeck upgrades RXO (NYSE:RXO) from Underweight to Neutral and raises the price target from $22 to $30.